BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 29247858)

  • 41. Novel potential drug against T. cruzi and its interaction with surfactant micelles.
    Rangel-Yagui CO; Hsu HW; Barbosa LR; Caetano W; Pessoa A; Tavares LC; Itri R
    Pharm Dev Technol; 2007; 12(2):183-92. PubMed ID: 17510890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents.
    Paula FR; Jorge SD; de Almeida LV; Pasqualoto KF; Tavares LC
    Bioorg Med Chem; 2009 Apr; 17(7):2673-9. PubMed ID: 19303308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
    Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi.
    de Souza VA; da Silva R; Pereira AC; Royo Vde A; Saraiva J; Montanheiro M; de Souza GH; da Silva Filho AA; Grando MD; Donate PM; Bastos JK; Albuquerque S; e Silva ML
    Bioorg Med Chem Lett; 2005 Jan; 15(2):303-7. PubMed ID: 15603944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and Evaluation of Nifurtimox-Adamantane Adducts with Trypanocidal Activity.
    Foscolos AS; Papanastasiou I; Tsotinis A; Taylor MC; Kelly JM
    ChemMedChem; 2019 Jul; 14(13):1227-1231. PubMed ID: 31066972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2-(phenylthio)ethylidene derivatives as anti-Trypanosoma cruzi compounds: Structural design, synthesis and antiparasitic activity.
    Cardoso MVO; Oliveira Filho GB; Siqueira LRP; Espíndola JWP; Silva EBD; Mendes APO; Pereira VRA; Castro MCAB; Ferreira RS; Villela FS; Costa FMRD; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2019 Oct; 180():191-203. PubMed ID: 31306906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural Optimization and Biological Activity of Pyrazole Derivatives: Virtual Computational Analysis, Recovery Assay and 3D Culture Model as Potential Predictive Tools of Effectiveness against
    Orlando LMR; Lechuga GC; da Silva Lara L; Ferreira BS; Pereira CN; Silva RC; Dos Santos MS; Pereira MCS
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of Strong 3-Nitro-2-Phenyl-
    Carey SM; O'Neill DM; Conner GB; Sherman J; Rodriguez A; D'Antonio EL
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mammea type coumarins isolated from Calophyllum brasiliense induced apoptotic cell death of Trypanosoma cruzi through mitochondrial dysfunction, ROS production and cell cycle alterations.
    Rodríguez-Hernández KD; Martínez I; Reyes-Chilpa R; Espinoza B
    Bioorg Chem; 2020 Jul; 100():103894. PubMed ID: 32388434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis, molecular modelling, and in vitro evaluation of tricyclic coumarins against Trypanosoma cruzi.
    Coelho GS; Andrade JS; Xavier VF; Sales Junior PA; Rodrigues de Araujo BC; Fonseca KDS; Caetano MS; Murta SMF; Vieira PM; Carneiro CM; Taylor JG
    Chem Biol Drug Des; 2019 Mar; 93(3):337-350. PubMed ID: 30362274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and antitrypanosomal activity of some nitrofurazone 1,2,4-triazolic bioisosteric analogues.
    Silva FT; Franco CH; Favaro DC; Freitas-Junior LH; Moraes CB; Ferreira EI
    Eur J Med Chem; 2016 Oct; 121():553-560. PubMed ID: 27318979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic Screening In Vitro of Novel Aromatic Amidines against Trypanosoma cruzi.
    Simões-Silva MR; Nefertiti AS; De Araújo JS; Batista MM; Da Silva PB; Bahia MT; Menna-Barreto RS; Pavão BP; Green J; Farahat AA; Kumar A; Boykin DW; Soeiro MN
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4701-7. PubMed ID: 27216059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against
    Lara LS; Lechuga GC; Moreira CDS; Santos TB; Ferreira VF; da Rocha DR; Pereira MCS
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ligand-based design, synthesis, and experimental evaluation of novel benzofuroxan derivatives as anti-Trypanosoma cruzi agents.
    Jorge SD; Palace-Berl F; Mesquita Pasqualoto KF; Ishii M; Ferreira AK; Berra CM; Bosch RV; Maria DA; Tavares LC
    Eur J Med Chem; 2013 Jun; 64():200-14. PubMed ID: 23644203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New Imidazole-Based Compounds Active Against Trypanosoma cruzi.
    Adeyemi OS; Molina MT; Eseola AO; Fonseca-Berzal C; Gómez-Barrio A
    Comb Chem High Throughput Screen; 2017; 20(1):20-24. PubMed ID: 28071587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
    Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
    Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of proline analogs as trypanocidal agents through the inhibition of a Trypanosoma cruzi proline transporter.
    Sayé M; Fargnoli L; Reigada C; Labadie GR; Pereira CA
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2913-2921. PubMed ID: 28844978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel 2-arylazoimidazole derivatives as inhibitors of Trypanosoma cruzi proliferation: Synthesis and evaluation of their biological activity.
    Salerno A; Celentano AM; López J; Lara V; Gaozza C; Balcazar DE; Carrillo C; Frank FM; Blanco MM
    Eur J Med Chem; 2017 Jan; 125():327-334. PubMed ID: 27688187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dehydrodieugenol B derivatives as antiparasitic agents: Synthesis and biological activity against Trypanosoma cruzi.
    Ferreira DD; Sousa FS; Costa-Silva TA; Reimão JQ; Torrecilhas AC; Johns DM; Sear CE; Honorio KM; Lago JHG; Anderson EA; Tempone AG
    Eur J Med Chem; 2019 Aug; 176():162-174. PubMed ID: 31103897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.